The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on therapeutic sialendoscopy.

Description

The salivary glands are located around the mouth and the throat. These glands may at times be blocked, usually because of stones. Sialendoscopy involves the use of a flexible tube (endoscope) to enter a salivary gland and to visualise and remove the stone.

Coding recommendations

A code(s) is selected dependent upon the site and nature of the procedure:

F51.1 Open extraction of calculus from parotid duct

Y76.3 Endoscopic approach to other body cavity

or

F51.2 Open extraction of calculus from submandibular duct

Y76.3 Endoscopic approach to other body cavity

or

F55.1 Dilation of parotid duct

Y76.3 Endoscopic approach to other body cavity

or

F55.2 Dilation of submandibular duct

Y76.3 Endoscopic approach to other body cavity

or

F51.8 Other specified open extraction of calculus from salivary duct

Y76.3 Endoscopic approach to other body cavity

Z26.3 Sublingual gland

Note: If a stent is inserted then Y14.- Placement of stent in organ NOC can be used in addition.

Your responsibility

This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account, and specifically any special arrangements relating to the introduction of new interventional procedures. The guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer. 

All problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the Yellow Card Scheme.

Commissioners and/or providers have a responsibility to implement the guidance, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties. Providers should ensure that governance structures are in place to review, authorise and monitor the introduction of new devices and procedures.

Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.